CME Group dividend profile draws analyst focus, shares supported by NASDAQ listing

CME Group sits in the S&P 500 with a 2.31 percent dividend yield and fresh analyst commentary on its NASDAQ-listed shares. Coverage from TD Cowen and Keefe Bruyette underlines the derivatives operator’s role in global risk management.

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-27, 14:44.

CME Group Inc. (US12572Q1058) remains a core derivatives operator on the NASDAQ, combining a global futures marketplace with a dividend yield of around 2.31 percent according to recent analyst compilations. Fresh notes from TD Cowen and Keefe Bruyette keep the stock in focus for long-term income and risk-management investors.

What recent analyst reports say

TD Cowen trimmed its price target for CME Group on 22 June 2026 from 332 dollars to 273 dollars, while reiterating a Buy rating on the shares and pointing to the firm’s position among NASDAQ dividend names. The house highlights CME’s diversified derivatives franchise and stable cash flows as reasons to keep its positive stance.

Keefe Bruyette & Woods upgraded CME Group from Market Perform to Outperform on 18 June 2026, leaving its price target unchanged at 305 dollars per share as it assessed the operator’s earnings visibility. The analyst note emphasizes the company’s leveraged exposure to global interest-rate and volatility cycles through its futures complex.

How the long-term profile looks

The latest data set CME Group’s annual dividend yield at roughly 2.31 percent, placing the stock among widely cited NASDAQ names for income strategies in the United States. The distribution reflects a cash-generative model built on transaction fees, clearing revenues and market-data licensing rather than one-off events.

Several forecasting services note a consensus analyst price target in the mid-200-dollar range, clustering around a level moderately above the current market price of about 221 dollars per share. These screens underline that the stock is followed by a broad analyst community, with differing views on valuation but consistent acknowledgment of CME’s central role in derivatives trading.

What the company sells

CME Group operates a multi-asset derivatives marketplace that spans interest-rate, equity-index, foreign-exchange, agricultural, energy and metals futures and options. Its flagship contracts include Eurodollar, SOFR and Treasury futures along with E-mini S&P 500 and options on these benchmarks, used by banks, asset managers and corporations for hedging and price discovery.

Where the stock trades today

CME Group shares (US12572Q1058) trade on the NASDAQ at 221.00 dollars as of 2026-06-26, 16:00 Eastern Time, with an after-hours indication at 222.00 dollars. The listing places the stock within the S&P 500 universe of large-cap US equities.

CME Group at a glance

• Company: CME Group Inc.
• ISIN: US12572Q1058
• WKN: A0MX9X
• Ticker: CME
• Trading venue: NASDAQ
• Price (as of 2026-06-26, 16:00): 221.00 USD
• Market cap: around 80 billion USD (as of 2026-06-26)
• Sector / industry: Financials - Exchanges & Data Services
• Index membership: S&P 500
• Next earnings date: not officially scheduled

Disclaimer: This article provides factual information on CME Group Inc. and does not contain investment advice, recommendations or solicitations to buy or sell securities.